Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.

Article  PubMed  Google Scholar 

Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359:1367–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cainap C, Balacescu O, Cainap SS, Pop L-A. Next generation sequencing technology in lung cancer diagnosis. Biology. 2021;10:864.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan AC, Tan DSW. Targeted therapies for lung cancer patients with oncogenic driver molecular alterations. J Clin Oncol Off J Am Soc Clin Oncol. 2022;40:611–25.

Article  CAS  Google Scholar 

Kohno T, Nakaoku T, Tsuta K, Tsuchihara K, Matsumoto S, Yoh K, et al. Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer. Transl Lung Cancer Res. 2015;4:156–64.

CAS  PubMed  PubMed Central  Google Scholar 

Chen Y-J, Roumeliotis TI, Chang Y-H, Chen C-T, Han C-L, Lin M-H, et al. Proteogenomics of non-smoking lung cancer in East Asia delineates molecular signatures of pathogenesis and progression. Cell. 2020;182:226–244.e17.

Article  CAS  PubMed  Google Scholar 

Kawaguchi T, Matsumura A, Fukai S, Tamura A, Saito R, Zell JA, et al. Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2010;5:1001–10.

Google Scholar 

Zhou W, Christiani DC. East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians. Chin J Cancer. 2011;30:287–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Yang H, Teo ASM, Amer LB, Sherbaf FG, Tan CQ, et al. Genomic landscape of lung adenocarcinoma in East Asians. Nat Genet. 2020;52:177–86.

Article  CAS  PubMed  Google Scholar 

Chen J, Yang H, Teo ASM, Amer LB, Sherbaf FG, Tan CQ, et al. Genomic landscape of lung adenocarcinoma in East Asians. European Genome-phenome Archive (EGA) (accession ID EGAD00001004422). 2020. https://ega-archive.org/datasets/EGAD00001004422

Chen J, Yang H, Teo ASM, Amer LB, Sherbaf FG, Tan CQ, et al. Genomic landscape of lung adenocarcinoma in East Asians. European Genome-phenome Archive (EGA) (accession ID EGAD00001004421). 2020. https://ega-archive.org/datasets/EGAD00001004421

Wu K, Zhang X, Li F, Xiao D, Hou Y, Zhu S, et al. Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas. Nat Commun. 2015;6:10131.

Article  CAS  PubMed  Google Scholar 

Gupte R, Liu Z, Kraus WL. PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes. Genes Dev. 2017;31:101–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kickhoefer VA, Siva AC, Kedersha NL, Inman EM, Ruland C, Streuli M, et al. The 193-Kd vault protein, Vparp, is a novel Poly(Adp-Ribose) polymerase. J Cell Biol. 1999;146:917–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Slesina M, Inman EM, Moore AE, Goldhaber JI, Rome LH, Volknandt W. Movement of vault particles visualized by GFP-tagged major vault protein. Cell Tissue Res. 2006;324:403–10.

Article  CAS  PubMed  Google Scholar 

Kickhoefer VA, Rajavel KS, Scheffer GL, Dalton WS, Scheper RJ, Rome LH. Vaults are up-regulated in multidrug-resistant cancer cell lines. J Biol Chem. 1998;273:8971–4.

Article  CAS  PubMed  Google Scholar 

Yu Z, Fotouhi-Ardakani N, Wu L, Maoui M, Wang S, Banville D, et al. PTEN associates with the vault particles in HeLa cells. J Biol Chem. 2002;277:40247–52.

Article  CAS  PubMed  Google Scholar 

van Zon A, Mossink MH, Schoester M, Houtsmuller AB, Scheffer GL, Scheper RJ, et al. The formation of vault-tubes: a dynamic interaction between vaults and vault PARP. J Cell Sci. 2003;116:4391–400.

Article  PubMed  Google Scholar 

Liu Y, Snow BE, Kickhoefer VA, Erdmann N, Zhou W, Wakeham A, et al. Vault poly(ADP-ribose) polymerase is associated with mammalian telomerase and is dispensable for telomerase function and vault structure in vivo. Mol Cell Biol. 2004;24:5314–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raval-Fernandes S, Kickhoefer VA, Kitchen C, Rome LH. Increased susceptibility of vault poly(ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis. Cancer Res. 2005;65:8846–52.

Article  CAS  PubMed  Google Scholar 

Alimirzaie S, Mohamadkhani A, Masoudi S, Sellars E, Boffetta P, Malekzadeh R, et al. Mutations in known and novel cancer susceptibility genes in young patients with pancreatic cancer. Arch Iran Med. 2018;21:228–33.

PubMed  Google Scholar 

Cirello V, Colombo C, Pogliaghi G, Proverbio MC, Rossi S, Mussani E, et al. Genetic variants of PARP4 gene and PARP4P2 pseudogene in patients with multiple primary tumors including thyroid cancer. Mutat Res. 2019;816–818:111672.

Article  PubMed  Google Scholar 

Ikeda Y, Kiyotani K, Yew PY, Kato T, Tamura K, Yap KL, et al. Germline PARP4 mutations in patients with primary thyroid and breast cancers. Endocr Relat Cancer. 2016;23:171–9.

Article  CAS  PubMed  Google Scholar 

Prawira A, Munusamy P, Yuan J, Chan CHT, Koh GL, Shuen TWH, et al. Assessment of PARP4 as a candidate breast cancer susceptibility gene. Breast Cancer Res Treat. 2019;177:145–53.

Article  CAS  PubMed  Google Scholar 

Chen J, Yang H, Teo ASM, Amer LB, Sherbaf FG, Tan CQ, et al. Genomic landscape of lung adenocarcinoma in East Asians. OncoSG Data Portal (Lung Adenocarcinoma (NCCS/GIS, 2020)). 2020. https://src.gisapps.org/OncoSG_public/study/summary?id=GIS031

Győrffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharmacol. 2024;181:362–74.

Article  PubMed  Google Scholar 

Győrffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Kaplan-Meier Plotter (Lung Adenocarcinoma). 2024. https://kmplot.com/analysis/index.php?p=service&cancer=lung

Park S-J, Yoon B-H, Kim S-K, Kim S-Y. GENT2: an updated gene expression database for normal and tumor tissues. BMC Med Genomics. 2019;12:101.

Article  PubMed  PubMed Central  Google Scholar 

Park S-J, Yoon B-H, Kim S-K, Kim S-Y. GENT2: an updated gene expression database for normal and tumor tissues 2019. http://gent2.appex.kr/

Blanco R, Iwakawa R, Tang M, Kohno T, Angulo B, Pio R, et al. A gene-alteration profile of human lung cancer cell lines. Hum Mutat. 2009;30:1199–206.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;7(7):20.

Google Scholar 

Hynds RE, Ben Aissa A, Gowers KHC, Watkins TBK, Bosshard-Carter L, Rowan AJ, et al. Expansion of airway basal epithelial cells from primary human non-small cell lung cancer tumors. Int J Cancer. 2018;143:160–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mirdita M, Schütze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold: making protein folding accessible to all. Nat Methods. 2022;19:679–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ho TLF, Lee MY, Goh HC, Ng GYN, Lee JJH, Kannan S, et al. Domain-specific p53 mutants activate EGFR by distinct mechanisms exposing tissue-independent therapeutic vulnerabilities. Nat Commun. 2023;14:1726.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Case DA, Ben-Shalom IY, Brozell SR, Cerutti DS, Cheatham TE, Cruzeiro VWD, et al. AMBER 2018. San Francisco: University of California; 2018.